The kit uses a centrifuge-free method for collecting aspirate with minimal contaminants. It has a diamond-tip trocar that works with CELLect filtration technology to reduce bone spicules and other impurities.
“Our aim was to create a minimally invasive solution that simplifies the aspiration process while optimizing cell quality,” Travis Greenhalgh, CEO of SurGenTec, said in the release. “The B-MAN Kit preserves native cell structure and facilitates the extraction of healthier cells by reducing the manipulation that takes place, providing physicians with a robust autologous option for patient treatment.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
